Abstract
Assessment was made of 5% local guanethidine in treating eye manifestations in euthyroid patients with either treated thyrotoxicosis or ophthalmic Graves's disease. In a double-blind crossover study guanethidine caused greater improvement in lid retraction than a control solution. A long-term study showed that this improvement was maintained. A much lower incidence of side-effects was noted with 5% guanethidine than with 10% solution.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bowden A. N., Rose F. C. Dysthyroid eye disease. A trial of guanethidine eye drops. Br J Ophthalmol. 1969 Apr;53(4):246–251. doi: 10.1136/bjo.53.4.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cant J. S., Lewis D. R., Harrison M. T. Treatment of dysthyroid ophthalmopathy with local guanethidine. Br J Ophthalmol. 1969 Apr;53(4):233–238. doi: 10.1136/bjo.53.4.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cant J. S., Lewis D. R. Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction. Br J Ophthalmol. 1969 Apr;53(4):239–245. doi: 10.1136/bjo.53.4.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crombie A. L., Lawson A. A. Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction. Br Med J. 1967 Dec 9;4(5579):592–595. doi: 10.1136/bmj.4.5579.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hall R., Storey E., Farmer F. T. Ophthalmic Graves' disease--clinical and laboratory features. Proc R Soc Med. 1968 Dec 12;61(12):1305–1306. doi: 10.1177/003591576806101234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sneddon J. M., Turner P. Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet. 1966 Sep 3;2(7462):525–527. doi: 10.1016/s0140-6736(66)92881-9. [DOI] [PubMed] [Google Scholar]